Skip to content

The efficacy of red yeast rice (Monascus pilosus) for primary hyperlipidemia: analysis and comparison of randomized controlled clinical trials

Red yeast rice for primary hyperlipidemia treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014883
Enrollment
Unknown
Registered
2018-02-12
Start date
2011-04-01
Completion date
Unknown
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia

Interventions

M:monacolin k-riched red yeast rice
G:Gamma-Aminobutryic Acid (GABA)-riched red yeast rice

Sponsors

development department, Gunze Limited, Japan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
29 Years to 64 Years

Inclusion criteria

Inclusion criteria: Before the exclusion were interviewed by internal medicinal physicians at Chang-Gung Memorial hospital in a preliminary screening, subjects met the criteria (LDL >100 mg/dl, TC > 200 mg/dl) will be included.

Exclusion criteria

Exclusion criteria: Some subjects were excluded from the study due to the following factors: 1) take hormone replacement therapy or immunosuppressive agents, 2) take the lipid-regulating drugs, 3) take the drugs known to affect lipid concentrations, 4) take the drugs known to be associated with rhabdomyolysis, cardiovascular disease, severe systemic and chronic disease, malignant neoplasm, 5) pregnancy, 6) receive insulin or oral hypoglycemic agents 7) have an endocrine disease related to lipid abnormalities.

Design outcomes

Primary

MeasureTime frame
Blood pressure, cholesterol, LDL, HDL, triglyceride, renal function, liver function and liver transaminase;

Secondary

MeasureTime frame
monacolin K, C-reactive protein, incidences of acute cardiovascular events, Interleukin-6, C-reactive protein (CRP) and inflammation related immune cells (CD4+ T cells, NK cells);

Countries

China

Contacts

Public ContactSien-Hung Yang

Chang Gung Memorial Hospital

dryang@cgmh.org.tw+886 3 3281200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026